Komori
Japan Medical Dynamic Marketing (7600) · InitiativeRestated

Adoption of the Revenue Recognition Accounting Standard and Deduction of Rebates from Net Sales

First written in FY2022-Q1. 5 of 6 entries say "Restated". Latest entry: FY2025-H1.

6entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022-Q1 – FY2025-H12021: 220212022: 020222023: 120232024: 32024
Same theme, other companies

4 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2025-H1RestatedAnnual report

    「Because the Revenue Recognition Standard is applied to sales in Japan, a portion of sales promotion expenses is deducted from sales.」

    Under the Revenue Recognition Standard, a portion of sales promotion expenses continues to be deducted from sales in the presentation.
  2. FY2024RestatedAnnual report

    「Because the Revenue Recognition Standard is applied to sales in Japan, a portion of sales promotion expenses is deducted from sales.」

    Under the Revenue Recognition Standard, a portion of sales promotion expenses continues to be deducted from sales in the presentation.
  3. FY2024-Q3RestatedAnnual report

    「In Japan, despite the impact of the reimbursement price cut implemented in April 2023, the increase in cases acquired resulted in revenue of ¥9,541 million, up ¥560 million, or 6.2%, year on year, after deducting part of selling expenses following the application of the Accounting Standard for Revenue Recognition.」

    Sales continue to be presented after deducting a portion of sales promotion expenses following adoption of the Revenue Recognition Standard.
  4. FY2024-Q2RestatedAnnual report

    「In Japan, despite the impact of the reimbursement price cut implemented in April 2023, the increase in cases acquired resulted in revenue of ¥6,129 million, up ¥324 million, or 5.6%, year on year, after deducting part of selling expenses following the application of the Accounting Standard for Revenue Recognition.」

    The deduction of a portion of sales promotion expenses following adoption of the Revenue Recognition Standard continues to be presented.
  5. FY2022-Q2RestatedAnnual report

    「Accordingly, for transactions involving rebates based on transaction volumes and other factors over a specified period, the amount of variable consideration, previously recorded as part of sales promotion expenses under selling, general and administrative expenses, has been deducted from sales since the first quarter consolidated cumulative period. As a result, sales and selling, general and administrative expenses each decreased by ¥130.289 million in the current second quarter consolidated cumulative period, with no impact on operating income, ordinary income or profit before income taxes.」

    The deduction of rebates from sales under the Revenue Recognition Standard, adopted from the first quarter, continued in the current quarter. Sales and selling, general and administrative expenses each decreased by ¥130.289 million, with no impact on profit.
  6. FY2022-Q1First statedAnnual report

    「The Company adopted the "Accounting Standard for Revenue Recognition" (ASBJ Statement No. 29, 31 March 2020; hereinafter, the "Revenue Recognition Standard") and related standards from the beginning of the first quarter of the current consolidated fiscal year. Revenue is recognized at the amount expected to be received in exchange for the promised goods or services when control of those goods or services is transferred to the customer. Accordingly, for transactions involving rebates based on transaction volumes and other factors over a specified period, the amount of variable consideration, previously recorded as part of sales promotion expenses under selling, general and administrative expenses, has been deducted from sales since the first quarter of the current consolidated cumulative period. As a result, sales and selling, general and administrative expenses each decreased by ¥61.935 million in the current first quarter consolidated cumulative period, with no impact on operating income, ordinary income or profit before income taxes.」

    The Revenue Recognition Standard and related standards were adopted from the beginning of the current quarter, changing the treatment of rebates so that they are deducted from sales rather than recorded under selling, general and administrative expenses. Sales and selling, general and administrative expenses each decreased by ¥61.935 million, with no impact on operating income or other profit measures.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Japan Medical Dynamic Marketing's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Adoption of the Revenue Recognition Accounting Standard and Deduction of Rebates from Net Sales | Japan Medical Dynamic Marketing,INC. (7600) | Komori